Home/Filings/4/0000950170-24-098859
4//SEC Filing

Chambers Michael Andrew 4

Accession 0000950170-24-098859

CIK 0000873303other

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 8:00 AM ET

Size

9.9 KB

Accession

0000950170-24-098859

Insider Transaction Report

Form 4
Period: 2024-08-16
Transactions
  • Purchase

    Common Stock

    2024-08-16$133.07/sh+13,106$1,744,015260,102 total(indirect: By Trust)
  • Purchase

    Common Stock

    2024-08-16$134.06/sh+18,284$2,451,153278,386 total(indirect: By Trust)
  • Purchase

    Common Stock

    2024-08-16$134.66/sh+5,648$760,560284,034 total(indirect: By Trust)
Holdings
  • Common Stock

    8,277
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $132.46 to $133.46, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $133.47 to $134.47, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $134.48 to $134.82, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Documents

1 file

Issuer

Sarepta Therapeutics, Inc.

CIK 0000873303

Entity typeother

Related Parties

1
  • filerCIK 0001932527

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 8:00 AM ET
Size
9.9 KB